Two prospective trials of immunotherapy in thyroid cancer, one of them negative, provided support for precision-medicine approaches that include immunotherapy. The studies were reported simultaneously ...

NATICK, Mass.--(BUSINESS WIRE)--AffyImmune Therapeutics, a clinical-stage biotechnology company committed to developing novel, first-in-class CAR T cell therapies, today announced early results from a ...

Researchers from The University of Texas MD Anderson Cancer Center demonstrated that anti-PD-L1 immunotherapy in combination with mutation-directed targeted therapy extended overall survival (OS) in ...

Anaplastic thyroid cancer (ATC), a rare yet highly aggressive malignancy, continues to represent a major clinical challenge. A recent review published in Genes & Diseases offers a comprehensive ...

Alan Streifel, Fargo, is undergoing radiation and chemotherapy for anaplastic thyroid cancer which has metastasized to his lungs. He has continued to work at Lunde-Kia to maintain his insurance ...

PHILADELPHIA--(BUSINESS WIRE)--FORE Biotherapeutics, a registration stage biotherapeutics company dedicated to developing targeted therapies to treat patients with cancer, today presented new ...

Differentiated thyroid cancers (DTC) and anaplastic thyroid cancers (ATC) often develop primary and acquired resistance to standard treatments. This highlights the need for new therapeutic strategies ...

Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit From Olaparib and Bevacizumab Maintenance in Ovarian Cancer Retrospective cohort study of patients with ATC and at ...

Thyroid Awareness Month highlights why thyroid health matters, common disorders, screening tests, and how early detection can protect mood, weight, and overall well-being.